Kewaunee Scientific Corporation's ability to collect accounts receivable sequentially worsen to 4.8, indicating more challenging environment then in the fourth quarter 2026, but still, it is a far cry from any concerns. Kewaunee Scientific's Accounts Receivable average collection period in the Jul 31 2026 quarter, has increased to 76 days, from 74 days, in the Apr 30 2026 quarter.

If we take a look into Healthcare sector 33 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 469, from overall ranking in the fourth quarter 2026 at 2952.

What is Receivable Turnover Ratio?
What is Kewaunee Scientific Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KEQU Receivables Turnover Ratio	(Jul 31 2026) I. Quarter	(Apr 30 2026) IV. Quarter	(Jan 31 2026) III. Quarter	(Oct 31 2025) II. Quarter	(Jul 31 2025) I. Quarter
Y / Y Receivable Change	2.28 %	-5.84 %	-5.73 %	40.9 %	30.66 %
Y / Y Revenue Change	-6.5 %	-9.66 %	3.26 %	48.49 %	49.36 %
Receivable Turnover Ratio (TTM)	4.8	4.91	4.96	4.85	4.82
KEQU's Total Ranking	# 469	# 2952	# 2793	# 2599	# 2445
Accounts Receivable average collection period days	76	74	74	75	76
Seq. Receivable Change	-0.92 %	8.51 %	-8.28 %	3.73 %	-8.8 %
Seq. Revenue Change	-7.11 %	4.17 %	-1.69 %	-1.71 %	-10.26 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 0
Healthcare Sector	# 34
Overall Market	# 469

Receivable Turnover Ratio Statistics
High	Average	Low
1.98	1.72	1.49
(Jul 31 2018)		(Apr 30 2026)

KEQU Company Profile • Back to KEQU Efficiency Comparisons • Compare KEQU Receivables Turnover Ratio to its Competitors

Financial Statements
Kewaunee Scientific's Accounts Receivable	$ 58 Millions	Visit KEQU's Balance sheet
Kewaunee Scientific's Sales TTM	$ 276 Millions	Visit KEQU's Income Statement
Sources of KEQU's Revenues		Visit KEQU's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KEQU's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KEQU's Growth Rates	KEQU's Roa	KEQU's Inventory Turnover Ratio	KEQU's Dividend Comparisons
KEQU's Profitability Ratios	KEQU's Roi	KEQU's Asset Turnover Ratio	KEQU's Dividend Growth
KEQU's Valuation Ratios	KEQU's Roe	KEQU's Financial Strength Ratios	KEQU's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jul 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jul 31 2026	Receivable at quarter ending Jul 31 2026
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Nrc Health	12.72	$ 139.996 Millions	$ 11.004 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.98	$ 8.855 Millions	$ 0.739 Millions
Teladoc Health Inc	11.88	$ 2,489.480 Millions	$ 209.556 Millions
Premier Air Charter Holdings Inc	11.72	$ 31.562 Millions	$ 2.692 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Option Care Health Inc	11.52	$ 5,692.934 Millions	$ 494.002 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Vaso Corporation	11.31	$ 80.220 Millions	$ 7.094 Millions
Innoviva Inc	11.22	$ 420.630 Millions	$ 37.491 Millions
Lifeloc Technologies Inc	11.19	$ 9.269 Millions	$ 0.828 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Radnet Inc	10.53	$ 2,268.932 Millions	$ 215.450 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Irhythm Holdings Inc	10.42	$ 825.702 Millions	$ 79.250 Millions
Integrated Biopharma Inc	10.38	$ 42.568 Millions	$ 4.101 Millions
Viemed Healthcare Inc	10.36	$ 301.606 Millions	$ 29.102 Millions
Lensar Inc	10.33	$ 60.264 Millions	$ 5.836 Millions
Immucell Corporation	10.30	$ 29.777 Millions	$ 2.891 Millions

Date modified: 2026-09-12T18:36:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.